Harvard Bioscience Inc

HBIO

Company Profile

  • Business description

    Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

  • Contact

    84 October Hill Road
    HollistonMA01746
    USA

    T: +1 508 893-8999

    E: [email protected]

    https://www.harvardbioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    355

Stocks News & Analysis

stocks

Market too pessimistic about unloved ASX health care share

Our analysts believe a long-term margin recovery is underway.
stocks

Two overvalued ASX shares to avoid

Both shares trade at a significant premium to our fair value.
stocks

Materially undervalued ASX tech share

Long reinvestment runway supports our thesis on ASX technology company.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,899.306.50-0.07%
CAC 408,025.8066.130.83%
DAX 4023,464.63225.450.97%
Dow JONES (US)47,112.45664.181.43%
FTSE 1009,609.5374.620.78%
HKSE26,012.34117.790.45%
NASDAQ23,025.59153.590.67%
Nikkei 22549,609.61950.091.95%
NZX 50 Index13,562.0181.580.61%
S&P 5006,765.8860.760.91%
S&P/ASX 2008,606.509.50-0.11%
SSE Composite Index3,876.916.890.18%

Market Movers